Leiomyoma Of Uterus Tissue Array, 80 Cases/80 Cores|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:173914

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Leiomyoma Of Uterus Tissue Array, 80 Cases/80 Cores)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2024年05月16日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

[在庫・価格 :2024年05月16日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Human, Leiomyoma of uterus, Tissue Array

文献数: 0

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Leiomyoma of uterus tissue microarray, single core per case 80 cases of leiomyoma of uterus
Cores: 80
組織アレイ
Cases: 80
Layout: 10 cols × 8 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Quality Control: Smooth muscle actin (SMA) confirmed
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Type †
A1 1 F 47 Uterus Leiomyoma Malignant
A2 2 F 45 Uterus Leiomyoma Malignant
A3 3 F 44 Uterus Leiomyoma Malignant
A4 4 F 42 Uterus Leiomyoma Malignant
A5 5 F 49 Uterus Leiomyoma Malignant
A6 6 F 50 Uterus Leiomyoma Malignant
A7 7 F 41 Uterus Leiomyoma Malignant
A8 8 F 46 Uterus Leiomyoma Malignant
A9 9 F 49 Uterus Leiomyoma Malignant
A10 10 F 50 Uterus Leiomyoma Malignant
B1 11 F 45 Uterus Leiomyoma Malignant
B2 12 F 48 Uterus Leiomyoma Malignant
B3 13 F 54 Uterus Leiomyoma Malignant
B4 14 F 45 Uterus Leiomyoma Malignant
B5 15 F 43 Uterus Leiomyoma with hyalinization Malignant
B6 16 F 33 Uterus Leiomyoma Malignant
B7 17 F 66 Uterus Leiomyoma with hyalinization Malignant
B8 18 F 44 Uterus Leiomyoma Malignant
B9 19 F 33 Uterus Leiomyoma Malignant
B10 20 F 66 Uterus Leiomyoma with hyalinization Malignant
C1 21 F 42 Uterus Leiomyoma Malignant
C2 22 F 34 Uterus Leiomyoma Malignant
C3 23 F 43 Uterus Leiomyoma Malignant
C4 24 F 33 Uterus Leiomyoma with mucous degeneration Malignant
C5 25 F 39 Uterus Leiomyoma Malignant
C6 26 F 45 Uterus Leiomyoma Malignant
C7 27 F 46 Uterus Leiomyoma Malignant
C8 28 F 29 Uterus Leiomyoma with mucous degeneration Malignant
C9 29 F 24 Uterus Leiomyoma with mucous degeneration Malignant
C10 30 F 45 Uterus Cellular leiomyoma Malignant
D1 31 F 51 Uterus Leiomyoma Malignant
D2 32 F 48 Uterus Leiomyoma Malignant
D3 33 F 49 Uterus Leiomyoma Malignant
D4 34 F 38 Uterus Leiomyoma Malignant
D5 35 F 48 Uterus Leiomyoma Malignant
D6 36 F 50 Uterus Leiomyoma Malignant
D7 37 F 44 Uterus Leiomyoma Malignant
D8 38 F 49 Uterus Leiomyoma Malignant
D9 39 F 56 Uterus Leiomyoma Malignant
D10 40 F 38 Uterus Leiomyoma with mucous degeneration Malignant
E1 41 F 47 Uterus Leiomyoma Malignant
E2 42 F 44 Uterus Leiomyoma Malignant
E3 43 F 42 Uterus Leiomyoma Malignant
E4 44 F 45 Uterus Leiomyoma Malignant
E5 45 F 52 Uterus Leiomyoma Malignant
E6 46 F 54 Uterus Leiomyoma Malignant
E7 47 F 53 Uterus Leiomyoma Malignant
E8 48 F 52 Uterus Leiomyoma Malignant
E9 49 F 51 Uterus Leiomyoma Malignant
E10 50 F 42 Uterus Leiomyoma Malignant
F1 51 F 46 Uterus Leiomyoma Malignant
F2 52 F 29 Uterus Leiomyoma Malignant
F3 53 F 32 Uterus Leiomyoma Malignant
F4 54 F 28 Uterus Leiomyoma Malignant
F5 55 F 54 Uterus Leiomyoma Malignant
F6 56 F 53 Uterus Leiomyoma Malignant
F7 57 F 39 Uterus Leiomyoma Malignant
F8 58 F 42 Uterus Leiomyoma Malignant
F9 59 F 50 Uterus Leiomyoma Malignant
F10 60 F 20 Uterus Leiomyoma Malignant
G1 61 F 96 Uterus Leiomyoma Malignant
G2 62 F 35 Uterus Leiomyoma Malignant
G3 63 F 63 Uterus Leiomyoma Malignant
G4 64 F 42 Uterus Leiomyoma Malignant
G5 65 F 43 Uterus Leiomyoma Malignant
G6 66 F 39 Uterus Leiomyoma Malignant
G7 67 F 55 Uterus Cellular leiomyoma Malignant
G8 68 F 43 Uterus Cellular leiomyoma Malignant
G9 69 F 46 Uterus Leiomyoma Malignant
G10 70 F 39 Uterus Leiomyoma Malignant
H1 71 F 53 Uterus Leiomyoma Malignant
H2 72 F 45 Uterus Cellular leiomyoma Malignant
H3 73 F 53 Uterus Leiomyoma Malignant
H4 74 F 46 Uterus Leiomyoma Malignant
H5 75 F 37 Uterus Leiomyoma Malignant
H6 76 F 48 Uterus Leiomyoma Malignant
H7 77 F 55 Uterus Leiomyoma Malignant
H8 78 F 46 Uterus Leiomyoma Malignant
H9 79 F 48 Uterus Leiomyoma Malignant
H10 80 F 32 Uterus Leiomyoma Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。